The potential for interaction of hydrochlorothiazide with garlic in rats

Chemico-Biological Interactions

Volumn 181, Issue 3, 2009, Pages 472-479

  Asdaq, Syed Mohammed Basheeruddin ^a   Inamdar, Mohammed Naseeruddin ^b  

^a KRUPANIDHI COLLEGE OF PHARMACY   (India)

^b AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

Garlic; Hydrochlorothiazide; Interaction; Isoproterenol

Indexed keywords

CATALASE; CREATINE KINASE MB; GARLIC EXTRACT; HYDROCHLOROTHIAZIDE; ISOPRENALINE; LACTATE DEHYDROGENASE; POTASSIUM; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIURESIS; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENTIATION; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE INJURY; HEART PROTECTION; HEART RATE; HEART STRESS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HOMOGENATE; HYPERTENSION; KALIURESIS; LACTATE DEHYDROGENASE BLOOD LEVEL; NONHUMAN; PHARMACODYNAMICS; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; QRS COMPLEX; QT INTERVAL; RAT; RR INTERVAL; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; ELECTROLYTES; FEMALE; FOOD-DRUG INTERACTIONS; GARLIC; HYDROCHLOROTHIAZIDE; RATS; RATS, WISTAR;

ALLIUM SATIVUM; RATTUS;

EID: 70349202032     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.07.022     Document Type: Article

References (56)

1. Blumenthal M. Herb market levels after five years of boom. Herbal Gram 47 (1999) 64-65
2. Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., and Mitchell A.A. Recent patterns of medication use in ambulatory adult population of the United States: the Slone survey. JAMA 287 (2003) 337-344
3. Klepser T.B., Doucette W.R., Horton M.R., Buys L.M., Ernst M.E., Ford J.K., Hoehns J.D., Kautzman H.A., Logemann C.D., Swegle J.M., Ritho M., and Klepser M.E. Assessment of patients' perceptions and beliefs regarding herbal therapies. Pharmacotherapy 20 (2000) 83-87
4. Fugh-Berman A. Herb-drug interaction. Lancet 355 (2000) 134-138
5. Opie L.H., and Kaplan N.M. Diuretics. In: Opie L.H. (Ed). Drugs for the Heart (1991), WB Saunders, Philadelphia, PA 74-99
6. Field M.J., Stanton B.A., and Giebisch G.H. Differential acute effects of aldosterone, dexamethasone, and hyperkalemia on distal tubular potassium secretion in the rat kidney. J. Clin. Invest. 74 (1984) 1792-1802
7. Schulman M., and Narins R.G. Hypokalemia and cardiovascular disease. Am. J. Cardiol. 65 (1990) 4-9
8. Hoes A.W., Grobbee D.E., Peet T.M., and Lubsen J. Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence. Drugs 47 (1994) 711-733
9. Krishna G.G. Effect of potassium intake on blood pressure. J. Am. Soc. Nephrol. 1 (1990) 43-52
10. Asdaq S.M.B., Inamdar M.N., Asad M., and Nanjundan P.K. Interaction of propranolol with garlic in isoproterenol induced myocardial infarction in rat. J. Pharmacol. Toxicol. 3 (2008) 414-424
11. Asdaq S.M.B., and Inamdar M.N. Pharmacodynamic interaction of garlic with captopril in ischemia-reperfusion induced myocardial damage in rats. Pharmacologyonline 2 (2008) 875-888
12. Banerjee S.K., Dinda A.K., Manchanda S.C., and Maulik S.K. Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury. BMC Pharmacol. 2 (2002) 16-24
13. Wiebelhaus V.D., Weinstock J., and Maass A.R. The diuretic and natriuretic activity of triamterene and several related pteridines in the rat. J. Pharmacol. Exp. Ther. 149 (1965) 397-403
14. Nedi T., Mekonnen N., and Urga K. Diuretic effect of the crude extracts of Carissa edulis in rats. J. Ethnopharmacol. 95 (2004) 57-64
15. Buerke I., Prufer D., Dahm M., Oelert H., Meyer J., and Darius H. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J. Pharmacol. Exp. Ther. 286 (1998) 429-438
16. Erich F., and Elastner M. Inhibition of nitrite formation from hydroxyl ammonium chloride. A simple assay of super oxide dismutase. Anal. Chem. 70 (1976) 616-620
17. Eva M.L. Mechanism of pH dependent hydrogen peroxide cytotoxicity in-vitro. Arch. Biochem. Biophys. 365 (1988) 362-372
18. Karthikeyan K., SaralaBai B.R., and Devaraj N. Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats. Int. J. Cardiol. 115 (2007) 326-333
19. Cooper M.J., Sinaiko A.R., Anders M.W., and Mirkin B.L. High Pressure liquid chromatographic determination of hydrochlorothiazide in human serum and urine. Anal. Chem. 48 (1976) 1110-1117
20. Okonta J.M., Uboh M., and Obonga W.O. Herb-drug interaction: a case study of effect of ginger on the pharmacokinetic of metronidazole in rabbit. Indian J. Pharm. Sci. 70 (2008) 230-232
21. Niemeyer C., Hasenfuß G., Wais U., Knauf U., Schäfer-Korting M., and Mutschler E. Pharmacokinetics of hydrochlorothiazide in relation to renal function. Eur. J. Clin. Pharmacol. 24 (1983) 661-665
22. Izzo A.A., Borrelli F., and Capasso R. Herbal medicine: the risk of drug interaction. Trends Pharmacol. Sci. 23 (2002) 358-359
23. Miller L.G. Herbal medicinal-selected clinical considerations focusing on known or potential drug-herb interactions. Arch. Intern. Med. 158 (1998) 2200-2211
24. Izzo A.A., and Ernst E. Interactions between herbal medicines and prescribed drugs. Drugs 61 (2001) 2163-2175
25. Williamson E.M. Synergy and other interactions in phytomedicines. Phytomedicine 8 (2001) 401-409
26. Aggarwal A., and Ades P.A. Interactions of herbal remedies with prescription cardiovascular medications. Coron. Artery Dis. 12 (2001) 581-584
27. Wittkowsky A.K. Drug interactions update: drugs, herbs, and oral anticoagulation. J. Thromb. Thrombolysis 12 (2001) 67-71
28. Villegas J.F., Barabe D.N., Stein R.A., and Lazar E. Adverse effects of herbal treatment of cardiovascular disease: what the physician must know. Heart Dis. 3 (2001) 169-175
29. Banerjee S.K., Maulik M., Mancahanda S.C., Dinda A.K., Gupta S.K., and Maulik S.K. Dose-dependent induction of endogenous antioxidants in rat heart by chronic administration of garlic. Life Sci. 70 (2002) 1509-1518
30. Asdaq S.M.B., Inamdar M.N., and Asad M. Effect of conventional antihypertensive drugs on hypolipidemic action of garlic in rats. Indian J. Exp. Biol. 47 (2009) 176-181
31. S.M.B. Asdaq, M.N. Inamdar, M. Asad, Pharmacodynamic interaction of garlic with propranolol in ischemia-reperfusion induced myocardial damage, Pak. J. Pharm. Sci., in press.
32. Jansen H., Muller B., and Knobloch K. Characterization of an alliin lyase preparation from garlic (Allium sativum). Planta Med. 55 (1989) 434-439
33. Ide N., and Lau B.H.S. Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury. J. Pharm. Pharmacol. 49 (1997) 908-911
34. Imai J., Ide N., Nagae S., Moriguchi T., Matsuura H., and Itakura Y. Antioxidants and free radical scavenging effects of aged garlic extract and its constituents. Planta Med. 60 (1994) 417-420
35. Wei Z., and Lau B.H.S. Garlic inhibits free radical generation and augments antioxidant enzyme activity in vascular endothelial cells. Nutr. Res. 18 (1998) 61-70
36. Lawson L.D. Garlic: a review of its medicinal effects and indicated active compounds. In: Lawson L.S., and Bauer R. (Eds). Phytomedicines of Europe: Chemistry and Biological Activity, ACS Symposium Series 691 (1988), American Chemical Society, Washington, D.C. pp. 176-209
37. Hayes M., Rushman T., and Goldberg M. Inhibition of hepatocarcinogenic responses to 1,2-dimethylhidrazine by diallyl sulfide, a component of garlic oil. Carcinogenesis 8 (1987) 1155-1157
38. Freeman F., and Kodera Y. Garlic chemistry: stability of S-(2-propenyl) 2-propene-1-sulfinothioate (allicin) in blood, solvents and simulated physio-logical fluids. J. Agric. Food Chem. 43 (1995) 2332-2338
39. Lawson L.D., Ransom D.K., and Hughs B.G. Inhibition of whole blood platelet aggregation by compounds in garlic clove extracts and commercial garlic products. Thromb. Res. 65 (1992) 141-156
40. McColl J.D., Parker J.M., and Ferguson J.K.W. Evaluation of some 1-and 7-substituted xanthines as diuretics in the rat. J. Pharmacol. Exp. Ther. 118 (1956) 162-167
41. Toratora G.R., and Grabowski S.R. Fluid, electrolyte and acid-base homeostasis. Principles of Anatomy and Physiology (2000), John Wiley and Sons, Inc., New York pp. 953-977
42. Chagoya D.S.Y., Hernandez-Munoz R., Lopez-Barrera F., Yanez L., Vidrio S., and Suarez J. Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Can. J. Physiol. Pharmacol. 75 (1997) 1300-1311
43. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell Cardiol. 17 (1985) 291
44. Mraz M., Kren V., Krsiakova D., Vrana A., and Hynie S. The role of myocardial glycogen content for the development of isoprenaline-induced myocardial lesions in different inbred strains of rats. Basic Res. Cardiol. 90 (1995) 467
45. Scheuer J., and Stezoski W.A.S. Protective role of increased myocardial glycogen stores in cardiac anoxia in the rat. Circ. Res. 27 (1970) 835
46. Brembilla-Perrot B., Chaise A.T., Van D.L., and Beurrier D. Effect of isoproterenol on serum and potassium and magnesium. Eur. Heart J. 14 (1993) 677
47. Singal P.K., Dhillon K.S., Beamish R.E., and Dhalla N.S. Protective effect of zinc against catecholamine-induced myocardial changes. Lab. Invest. 44 (1981) 426
48. Kumar S.H.S., Anandan R., Devaki T., and Kumar M.S. Cardioprotective effects of Picrorrhiza kurroa against isoproterenol-induced myocardial stress in rats. Fitoterapia 72 (2001) 402
49. Ajitha M., and Rajnaryana K. Role of oxygen free radicals in human disease. Indian Drugs 38 (2001) 545
50. 3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J. Clin. Invest. 102 (1998) 1377
51. Das D.K., Maulik N., and Moraru I.I. Gene expression in acute myocardial stress. Induction by hypoxia, ischemia/reperfusion, hyperthermia and oxidative stress. J. Mol. Cell. Cardiol. 27 (1995) 181-193
52. Faulx M.D., Ernsberger P., Vatner D., Hoffman R.D., Lewis W., and Strachan R. Strain-dependent β-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H30-H36
53. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87 (2000) 840-844
54. Benjamin H., and Lau S. Suppression of LDL oxidation by garlic. J. Nutr. 22 (2001) 985S-988S
55. Chung L.Y. The antioxidant properties of garlic compounds: allyl cysteine, alliin, allicin, and allyl disulfide. J. Med. Food 9 (2006) 205-213
56. Kodera Y. Dietry tolerance/absorption/metabolism of garlic. In: Lanchance P. (Ed). Nutraceutical: Desinger Food II Grade, Soy and Licorice (1997), Food and Nutrition Press, Trumbell, CT 95-105